Mycoses Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Mycoses Market
Mycoses Market: By Types of Fungi (dermatophytes, yeasts and molds, others), By Treatment (Photodynamic, Radiation, Chemotherapy, Targeted, Others) & By Region-Forecast (2018-2023)
Report Code : HCR 0297
Updated Date: 10 May, 2018  

1. Mycoses Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Mycoses Market– Market Forces
   4.1. Drivers
      4.1.1. Increasing prevalence of AIDS/HIV and weakened immune systems
      4.1.2. Large Population Base
      4.1.3. Recent development in technology
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Mycoses Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Mycoses Market, By Type of Fungi
   6.1. Dermatophytes
   6.2. Yeasts
   6.3. Molds
   6.4. others
7. Mycoses Market, By Treatment
   7.1. Photodynamic therapy
   7.2. Radiation therapy
   7.3. Chemotherapy
   7.4. Targeted therapy
   7.5. Drug Medication
8. Mycoses Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Mycoses – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Bayer AG
   10.2. Dr. Reddy's Laboratories Limited
   10.3. Helix BioMedix, Inc
   10.4. Merck & Co., Inc
   10.5. Pfizer, Inc
   10.6. Nuvo Research, Inc
   10.7. Moberg Derma AB
   10.8. Novabiotics Ltd
   10.9. Pacgen Biopharmaceuticals Corporation
   10.10. Quinnova Pharmaceuticals, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll